GBP1 and Ewing sarcoma: Two years after their initial publication, the same study group published the results of their second study, stating that the loss of BARD1 increases Ewing sarcoma sensitivity to DNA damage, and that Guanylate-binding protein 1 (GBP1) expression contributes to DNA damage response in Ewing sarcoma organoids [39].